Laxmi Organic Industries IPO - Anand Rathi’s Investment Rationale 
A researcher handles apparatus inside a laboratory. (Photographer Gilles Sabrie/Bloomberg)

Laxmi Organic Industries IPO - Anand Rathi’s Investment Rationale 


BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Anand Rathi Report

Laxmi Organic Industries Ltd. is a leading manufacturer of Acetyl Intermediates and specialty intermediates with almost three decades of experience in large scale manufacturing of chemicals.

It is currently among the largest manufacturers of ethyl acetate in India with a market share of approximately 30% of the Indian ethyl acetate market.

It is the only manufacturer of diketene derivatives in India with a market share of ~55% of the Indian diketene derivatives market in terms of revenue in fiscal 2020 and one of the largest portfolios of diketene products.

Click on the attachment to read the full report:

Anand Rathi IPO Note Laxmi Organic Industries.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.